SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern

Diferences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis

(2022) Kevin Yau et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

(2022) Laura A. VanBlargan et al.   NATURE MEDICINE

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

(2022) John P. Evans et al.   Science Translational Medicine

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

(2022) Anh Duc Dang et al.   VACCINE

Genetic Variants of SARS-CoV-2—What Do They Mean?

(2021) Adam S. Lauring et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK

(2021) Julian W. Tang et al.   JOURNAL OF INFECTION

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

(2021) Zhuoming Liu et al.   Cell Host & Microbe

How to redesign COVID vaccines so they protect against variants

(2021) Ewen Callaway et al.   NATURE

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

(2021) Annette B. Vogel et al.   NATURE

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

(2021) Rita E. Chen et al.   NATURE MEDICINE

A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike

(2021) Mijia Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model

(2021) Fatima Amanat et al.   mBio

Development of Pandemic Vaccines: ERVEBO Case Study

(2021) Jayanthi Wolf et al.   Vaccines

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

(2021) Kirill V. Kalnin et al.   npj Vaccines

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273

(2021) Deborah Steensels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters

(2021) Mijia Lu et al.   JOURNAL OF VIROLOGY

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar

(2021) Patrick Tang et al.   NATURE MEDICINE

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

(2021) Koen B. Pouwels et al.   NATURE MEDICINE

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans

(2021) Barbra A. Dickerman et al.   NEW ENGLAND JOURNAL OF MEDICINE

How bad is Omicron? Some clues are emerging

(2021) Kai Kupferschmidt et al.   SCIENCE

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

(2021) Weina Sun et al.   Nature Communications

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats

(2021) Johnstone Tcheou et al.   Frontiers in Immunology

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

(2020) Daniel Wrapp et al.   SCIENCE

Structural basis of receptor recognition by SARS-CoV-2

(2020) Jian Shang et al.   NATURE

Approaches and Challenges in SARS-CoV-2 Vaccine Development

(2020) Gabriel Dagotto et al.   Cell Host & Microbe

Lessons for COVID-19 Immunity from Other Coronavirus Infections

(2020) Alan Sariol et al.   IMMUNITY

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

(2020) Noe B. Mercado et al.   NATURE

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

(2020) Neeltje van Doremalen et al.   NATURE

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

(2020) Ann M. Arvin et al.   NATURE

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

(2020) Ching-Lin Hsieh et al.   SCIENCE

Distinct conformational states of SARS-CoV-2 spike protein

(2020) Yongfei Cai et al.   SCIENCE

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

(2020) Sarah R. Leist et al.   CELL

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

(2020) Denis Y Logunov et al.   LANCET

Spike mutation D614G alters SARS-CoV-2 fitness

(2020) Jessica A. Plante et al.   NATURE

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

(2020) Cheryl Keech et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlates of protection against SARS-CoV-2 in rhesus macaques

(2020) Katherine McMahan et al.   NATURE

Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

(2019) Scott A Halperin et al.   JOURNAL OF INFECTIOUS DISEASES

A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein

(2018) Anzhong Li et al.   Nature Communications

mRNA Cap Methylation Influences Pathogenesis of Vesicular Stomatitis Virus In Vivo

(2013) Y. Ma et al.   JOURNAL OF VIROLOGY

Vesicular Stomatitis Virus as a Vector To Deliver Virus-Like Particles of Human Norovirus: a New Vaccine Candidate against an Important Noncultivable Virus

(2011) Y. Ma et al.   JOURNAL OF VIROLOGY